RXRX

Q: What is the price of Recursion Pharmaceuticals Inc (RXRX) today?

The current price of Recursion Pharmaceuticals Inc (RXRX) is $ 3.28, representing a -43.06% gain over the past year. The stock began the year trading around $ 4.09 and is currently priced at $ 3.28. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Recursion Pharmaceuticals Inc (RXRX) pay dividends?

Recursion Pharmaceuticals Inc (RXRX) did not pay dividends over the past year.

Recursion Pharmaceuticals Inc

Price

$ 3.28

return (12m)

-43.06%

p/e

-2.66

p/bv

1.51

DIVIDEND YIELD

0.00%

RXRX price

RXRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment RXRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.30%

3 months

-29.61%

1 year

-43.06%

2 years

-63.23%

5 years

0.00%

10 years

0.00%

Fundamentals RXRX

review the fundamentals of Recursion Pharmaceuticals Inc shares

P/E

-2.66

Sector: 7.56 Industry: 7.56

P/S (PSR)

23.06

Sector: 2.27 Industry: 2.27

P/BV

1.51

Sector: 1.97 Industry: 1.97

DIVIDEND YIELD (DY)

0.00%

Sector: 0.67% Industry: 0.67%

ROA

-43.74%

Sector: 0.06% Industry: 0.06%

ROE

-57.01%

Sector: 4.23% Industry: 4.23%

ROIC

-56.66%

Sector: -74.34% Industry: -74.34%

NET MARGIN

-100.00%

Sector: 2.62% Industry: 2.62%

GROSS MARGIN

4.46%

Sector: 31.55% Industry: 31.55%

OPERATING MARGIN

-100.00%

Sector: 4.40% Industry: 4.40%

EV/EBITDA

-3.06

Sector: 2.98 Industry: 2.98

EV/EBIT

-2.66

Sector: 1.12 Industry: 1.12

PRICE-TO-ASSETS

1.16

Sector: 0.96 Industry: 0.96

BVPS

2.17

Sector: 9.42 Industry: 9.42

EPS

-1.24

Sector: 0.68 Industry: 0.68

EQUITY-TO-ASSETS RATIO

0.77

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.23

Sector: 0.51 Industry: 0.51

CAGR REVENUE 5 YEARS

49.33%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

28.16%

Sector: - Industry: -

Fundamentals RXRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	26.30	7.32	27.83%	0.33%	$ 1.59 T	30.08%
INTR	15.22	1.90	12.49%	1.38%	$ 3.62 B	15.62%
PBR	6.90	1.82	26.37%	5.54%	$ 138.61 B	22.13%
VALE	30.78	2.11	6.85%	5.97%	$ 72.40 B	6.12%
PLTR	188.11	40.82	21.70%	0.00%	$ 305.68 B	36.31%
SHEL	15.11	1.54	10.17%	3.14%	$ 269.53 B	6.68%
BDORY	11.55	0.81	6.98%	2.29%	$ 28.60 B	9.30%
MAIN	9.68	1.59	16.48%	7.47%	$ 4.77 B	83.37%
ENB	22.02	2.51	11.38%	5.01%	$ 118.42 B	11.49%
NSRGY	11.02	6.21	56.41%	3.39%	$ 257.76 B	10.91%
PBR-A	6.27	1.65	26.37%	5.51%	$ 125.98 B	22.13%
ITUB	13.19	2.72	20.61%	2.67%	$ 107.14 B	27.17%
UNH	22.87	2.71	11.85%	2.90%	$ 275.72 B	2.69%
BBSEY	8.64	7.41	85.85%	11.04%	$ 14.11 B	100.00%
SAN	11.84	1.45	12.24%	1.73%	$ 191.33 B	23.74%
TTE	15.65	1.75	11.17%	6.96%	$ 205.50 B	7.20%
RACE	34.07	0.00	0.00%	0.89%	$ 62.28 B	22.35%
TD	10.79	1.86	17.19%	2.99%	$ 169.19 B	34.54%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

RXRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc

Average Investor10 user rating

4.0 (9 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Recursion Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $1.71 Billion, with shareholders equity totaling $1.13 Billion.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Recursion Pharmaceuticals Inc reported $74.25 Millions in revenue, generating net income of $-644.76 Millions.

Key financial metrics include a P/E ratio of -2.66, a price-to-book (P/B) ratio of 1.51, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RXRX.

Market cap

$ 1.71 Billion

Net worth

$ 1.13 Billion

$ 1,130,870,000.00

Assets

$ 1.47 Billion

$ 1,474,130,000.00

Total Shares Outstanding

522.00 Millions

522,000,000

Average Daily Trading Volume

$ 17.01 Millions

$ 17,008,678.54

Sector

Others

Industry

Others

RXRX

RXRX revenue and profits

Financial Results RXRX

DRAG THE FRAME TO SEE MORE DATA

RXRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

SHG - Shinhan Financial Group Co Ltd

$ 67.31 114,20% (12M)

P/E

0.01

2.34%

ROE

0.00%

P/BV

0.00

ALIZY - Allianz SE ADR

$ 44.29 20,78% (12M)

P/E

1.48

3.85%

ROE

68.27%

P/BV

1.01

CRERF - Carrefour SA

$ 18.40 30,61% (12M)

P/E

2.50

6.97%

ROE

11.62%

P/BV

0.29

UNH - UnitedHealth Group Incorporated

$ 304.33 --47,80% (12M)

P/E

22.87

2.90%

ROE

11.85%

P/BV

2.71

STLA - Stellantis NV

$ 8.04 --1,99% (12M)

P/E

-1.15

8.89%

ROE

-32.04%

P/BV

0.37

COR - Cencora Inc.

$ 320.82 13,64% (12M)

P/E

38.30

0.72%

ROE

77.54%

P/BV

29.69

BLSH - Bullish

$ 36.23 --48,09% (12M)

P/E

-7.15

0.00%

ROE

-23.69%

P/BV

1.69

SHEL - Shell PLC ADR

$ 92.21 54,47% (12M)

P/E

15.11

3.14%

ROE

10.17%

P/BV

1.54